BNGO

Bionano Genomics (BNGO) P/E Ratio
P/E Ratio as of Oct 26, 2026: -0.31
Average-0.3724
Median-0.3700
Minimum-0.4600
Maximum-0.3000
-0.31
0.13 (29.55%)past month
The P/E ratio for Bionano Genomics (BNGO) is -0.31 as of Oct 26, 2026. This represents a increase of 63.16% compared to its 12-month average P/E ratio of -0.19. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Bionano Genomics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Bionano Genomics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Bionano Genomics to industry peers.
Bionano Genomics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Bionano Genomics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Bionano Genomics to industry peers.
Bionano Genomics (BNGO) P/E Ratio Insights
See Bionano Genomics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Bionano Genomics (BNGO)
Order type
Buy in
Order amount
Est. shares
0 shares
Bionano Genomics (BNGO) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $1.57 | -0.42 |
| Sep 1, 2026 | $1.22 | -0.33 |
| Aug 3, 2026 | $1.115 | -0.22 |
| Jul 1, 2026 | $1.17 | -0.23 |
| Jun 1, 2026 | $1.25 | -0.25 |
| May 1, 2026 | $1.18 | -0.22 |
| Apr 1, 2026 | $1.19 | -0.22 |
| Mar 2, 2026 | $1.14 | -0.07 |
| Feb 2, 2026 | $1.27 | -0.08 |
| Jan 2, 2026 | $1.59 | -0.10 |
Bionano Genomics (BNGO) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -0.31 | +210.00% |
| 2025 | -0.10 | -47.37% |
| 2024 | -0.19 | -29.63% |
| 2023 | -0.27 | -92.44% |
| 2022 | -3.57 | -68.90% |
| 2021 | -11.48 | — |
FAQs About Bionano Genomics (BNGO) P/E ratio
The latest P/E ratio of Bionano Genomics (BNGO) is -0.31, as of Oct 26, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Bionano Genomics’s last 12-month average P/E ratio is -0.19, compared to its current P/E ratio of -0.31. This reflects a increase of 63.16%.
Bionano Genomics’s current P/E ratio of -0.31 is higher than its last 12-month average P/E of -0.19. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Bionano Genomics’s average P/E ratio over the last 3 years is -0.15. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Bionano Genomics’s average P/E ratio over the last 5 years is -2.34. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
Bionano Genomics (BNGO) P/E Ratio Insights
See Bionano Genomics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Bionano Genomics (BNGO)
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.